Sickle_Cell_disease_screening_of_newborns_in_Metropolitan_France_in_2018.png
Size of this preview:
550 × 600 pixels
.
Other resolutions:
220 × 240 pixels
|
440 × 480 pixels
|
704 × 768 pixels
|
939 × 1,024 pixels
|
1,878 × 2,048 pixels
.
Summary
| Description |
English:
Percentage of newborns screened for Sickle Cell disease in Metropolitan France in 2018. This map does not depict the outcome of the screening. In Metropolitan France, newborns are screened for Sickle Cell disease when either parent originates from an at-risk region (see source, page 45).
Français :
Pourcentage des nouveaux-nés dépistés pour la drépanocytose en France Métropolitaine en 2018. Cette carte ne présente pas le résultat du dépistage. En France Métropolitaine, le dépistage de la drépanocytose est limité aux nouveaux-nés dont les parents sont originaires de régions à risque (voir source, page 45).
|
| Date | |
| Source | Own work , data taken from Rapport d’activité, Programmé National du dépistagé néonatal; 2018 |
| Author | Tweedle |
Licensing
I, the copyright holder of this work, hereby publish it under the following license:
This file is licensed under the
Creative Commons
Attribution-Share Alike 4.0 International
license.
-
You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
-
Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.